ProQR Therapeutics N.V. - PRQR Quarterly EPS earnings growth
ProQR Therapeutics N.V. (PRQR) management, possessing deep genetic expertise, is minimizing financial risks through a transparent alliance with Eli Lilly. Quarterly growth in net income per share demonstrates current capital dynamics, where 29.90 represents the latest metric reading. The strategy is based on the Axiomer platform for correcting hereditary pathologies. An innovative product portfolio in the expansion phase is opening new horizons for the therapy of rare diseases.
%20Year-over-year%20earnings%20per%20one%20share%20growth%20for%20the%20last%2012%20months&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_PRQR_-_ProQR-Therapeutics-N.V._-_Year-over-year-earnings-per-one-share-growth-for-the-last-12-months "ProQR Therapeutics NV - PRQR Quarterly EPS earnings growth (period 07/04/2022 - 11/14/2026) | 👁️GURU.Markets👁️")
PRQR (ProQR Therapeutics): analytical breakdowns and indicator data
- share price and consensus valuation forecast:
- issuer market value details:
- balance sheet net asset value indicators:
- business debt structure and liquidity details:
Total Debt to Capital ProQR Therapeutics N.V.|PRQR - Long-Term Debt to Capital|Short-Term Debt to Equity ProQR Therapeutics|PRQR - Company Aggregate Indebtedness|Debts to Book Capitalization ProQR Therapeutics NV|PRQR - Long-Term Debt|Company Current Liabilities ProQR Therapeutics N.V.|Quick Liquidity Indicator proqr.com
- earnings and valuation multiples indicators:
PRQR - Profit After Payment of Taxes|Projected Future Earnings ProQR Therapeutics N.V.|PRQR - Business Payback Period|Forward P/E Multiple ProQR Therapeutics NV|PRQR - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ProQR|PRQR - Operating income before deduction of amortization|Net earnings per share for the last 12 months ProQR Therapeutics N.V.|PRQR - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months proqr.com|PRQR - Earnings per share growth this year|Expected earnings per share growth for next year ProQR Therapeutics N.V.
- sales volume and revenue indicators:
General company analysis:ProQR - PRQR
Quarterly EPS growth measures the dynamics of net income per share, revealing hidden internal imbalances prior to the publication of reports. For ProQR Therapeutics N.V. (PRQR), the quarterly rate of EPS change reflects the monetization efficiency of the Axiomer platform through upfront payments from pharma behemoths. This chart allows for an assessment of the company's capital structure stability. The stability of this metric confirms the reliability of the current business model, signaling high-quality business fundamentals.
Analysis of competing companies
TEM: Quarterly EPS earnings growth|Qiagen Corp - Year-over-year earnings per one share growth for the last 12 months|IONS (Ionis Pharmaceuticals) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months RGEN (Repligen)|Quarterly EPS earnings growth RNA|CRSP (CRISPR Therapeutics) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth WGS (GeneDx Holdings Corp.)|RARE: Year-over-year earnings per share growth for the last 12 months|BEAM - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months sarepta.com|TWST: Quarterly EPS earnings growth|TXG - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Intellia|Earnings per share growth in annualized terms for the last twelve months Stoke Therapeutics STOK|Quarterly EPS earnings growth BLFS|Wave Life Sciences - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth MAZE (Maze Therapeutics, Inc.)|Quarterly EPS earnings growth Sionna Pharma SION|Prime Medicine Bio - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months TSHA (Taysha)|QURE: Quarterly EPS earnings growth|MGTX - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months RGNX|SLDB: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months ocugen.com (OCGN)|Year-over-year net earnings per share change for the last twelve months PacBio Corp|Year-over-year earnings per share growth for the last twelve months Benitec Biopharma BNTC|DSGN: Year-over-year earnings per share growth for the last 12 months|RCKT - Year-over-year earnings per share growth for the last twelve months|4dmoleculartherapeutics.com (FDMT) - Year-over-year net earnings per share growth for the last 12 months|lexeotx.com (LXEO) - Year-over-year earnings per share growth for the last twelve months|Korro Bio, Inc (KRRO) - Quarterly EPS earnings growth|EDIT (editasmedicine.com) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months SLN (silence-therapeutics.com)|Year-over-year net earnings per share growth for the last 12 months CDXS (Codexis Bio)|SGMO - Earnings per share growth in annualized terms for the last twelve months|Nautilus Biotechnology, Inc. - Year-over-year net earnings per share growth for the last 12 months|Net earnings per share growth for the trailing year Metagenomi, Inc|Precision BioSciences - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year generationbio.com (GBIO)|Boundless Bio Inc (BOLD) - Year-over-year earnings per share growth for the last twelve months|Exicure Inc. - Year-over-year earnings per one share growth for the last 12 months|IMNN (imunon.com) - Quarterly EPS earnings growth|Phio Pharmaceuticals - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Mustang Bio Corp (MBIO)|Quarterly EPS earnings growth TransCode (RNAZ)|Quarterly EPS earnings growth BNGO (bionanogenomics.com)|APDN (Applied DNA Sciences Inc) - Year-over-year net earnings per share trend for the last twelve months|BLUE - Year-over-year earnings per share growth for the last twelve months|ImmunoPrecise Antibodies Ltd. (IPA) - Year-over-year net earnings per share growth for the last 12 months|OMGA (Omega) - Year-over-year net earnings per share growth for the last 12 months|singulargenomics.com (OMIC) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months RGLS|Syros (SYRS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months telesisbio.com (TBIO)|TCON - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth UBX (Unity Biotechnology Inc.)
